Targeting the Vascular Endothelial Growth Factor Pathway in the Treatment of Human Malignancy
Author:
Publisher
Informa UK Limited
Subject
General Medicine,Immunology
Link
http://www.tandfonline.com/doi/pdf/10.1080/08820130600991794
Reference111 articles.
1. Effect of Antiangiogenic Therapy on Slowly Growing, Poorly Vascularized Tumors in Mice
2. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
3. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood–brain barrier and target glioma;AMB Express;2019-10-15
2. Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2019-01-07
3. Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells;Clinical Research and Practice;2017
4. Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems;BMC Cancer;2016-03-09
5. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2;American Journal of Physiology-Cell Physiology;2014-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3